In fact, PGE2 impairs DC migration in tumor‐draining lymph node and TME [148] in models of prostate cancer, and PGE2‐primed DC produce higher levels of the immunosuppressive cytokine IL‐10, which in turn downregulates their APC activity [149]. This evidence concerns the gene IL10 and neoplasm.